Treatment Rates for Mental Disorders among children and adolescents on the decline: JAMA

Written By :  Niveditha Subramani
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-10-20 14:30 GMT   |   Update On 2023-10-20 14:32 GMT

Anxiety, depression, attention-deficit/hyperactivity disorder (ADHD), and behavior disorders, such as oppositional-defiant disorder and conduct disorders, are the most common mental disorders among children and adolescents. It is reported that 75% of psychiatric diseases diagnosed among adults had roots in childhood or adolescence hence early treatment has become crucial. Reportedly...

Login or Register to read the full article

Anxiety, depression, attention-deficit/hyperactivity disorder (ADHD), and behavior disorders, such as oppositional-defiant disorder and conduct disorders, are the most common mental disorders among children and adolescents. It is reported that 75% of psychiatric diseases diagnosed among adults had roots in childhood or adolescence hence early treatment has become crucial.

Reportedly studies have provided discordant results regarding treatment rates for mental disorders among youths. A recent meta analysis suggests that the treatment rates of mental disorders among children and adolescents were generally low, especially for depression and anxiety; targeted interventions are needed to improve this situation. The findings are published in JAMA Network.

Researchers searcherd PubMed, Web of Science, PsycINFO, Scopus, and Embase were searched from database inception until September 23, 2022, and supplemented with hand-searching of reference lists. Included studies were those that used validated methods to report treatment rates for any mental disorder, depressive disorders, anxiety disorders, attention-deficit/hyperactivity disorder (ADHD), and behavior disorders among children and adolescents. Studies with a Joanna Briggs Institute score of 5 or more were included in the meta-analysis. Treatment rates were pooled using random-effects models. Subgroup analyses were performed to investigate the association with treatment rates of factors, such as year of data collection, World Health Organization region, age, income level, timeframe of diagnosis, informant source, service type, sample origin, and internalizing or externalizing disorder.

The key findings of the study are

• A total of 40 studies were included in the analysis, comprising 310 584 children and adolescents, with boys accounting for 39% of participants (sex was not reported in 10 studies).

• The pooled treatment rate was 38% for any mental disorder, 36% for depressive disorders, 31% for anxiety disorders, 58% for ADHD, and 49% for behavior disorders.

• Age, income level, and region were significantly associated with the combined treatment rates of mental disorders in children and adolescents.

• The treatment rate for depressive disorders was higher among adolescents than children (36% vs 11%), whereas the treatment rate for anxiety disorders was higher among children than adolescents (64% vs 20%).

• The treatment rate for any mental disorder in lower-middle income countries was 6%, in upper-middle income countries was 24%, and in high-income countries was 43%.

• For depressive disorders, treatment rates were higher in the Americas (40%) than in Europe (28%) and the Western Pacific region (6%).

Researchers concluded that “This study suggests that, in general, the treatment rates for mental disorders among children and adolescents were low, especially for depression and anxiety. Targeted intervention policies and effective measures should be designed and implemented to improve treatment rates of psychiatric disorders among youths.”

Reference: Wang S, Li Q, Lu J, et al. Treatment Rates for Mental Disorders Among Children and Adolescents: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2023;6(10):e2338174. doi:10.1001/jamanetworkopen.2023.38174.

Tags:    
Article Source : JAMA Network

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News